Considering that primary MET genomic amplification a low-frequency event in most tumors, the researchers developed an antibodydrug conjugate, telisotuzumabvedotin, also known as ABBV-399, which is composed of telisotuzumab and cytotoxic monomethyl auristatin E (MMAE) via a valinecitrulline linker (Wang et al., 2017)
Could it trigger a flare-up or exacerbate the condition
KIM-1 measurements appear to outperform traditional serum creatinine as a measure of acute organ damage, and this possibility deserves further research attention
PRP injection therapy is particularly effective for individuals suffering from tendon injuries, ligament damage, carpal tunnelrelated inflammation, and wrist arthritis
There is thus a need for robust tools that can quantify this critical redox modulator with subcellular specificity